# OMass Therapeutics funding rounds and investors

As of 15 Oct 2026, OMass Therapeutics has raised $310M across 1 verified round on record; latest: $310 million Series C led by Bain Capital Life Sciences, Forbion and 1 other, announced 14 Oct 2026.

Headquarters: Oxford, England  
Page: https://fireround.dev/companies/omass-therapeutics

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-10-14 | Series C | $310 million | Bain Capital Life Sciences, Forbion, Novo Holdings | British Business Bank, GV (Google Ventures), Janus Henderson Investors, Jefferson Life Sciences, Northpond Ventures, Oxford Science Enterprises, Sanofi Ventures, SV Health Investors, Syncona, University of Oxford | [fiercebiotech.com](https://www.fiercebiotech.com/biotech/why-omass-310m-series-c-fantastic-milestone-journey-become-britains-big-biotech), [european-biotechnology.com](https://european-biotechnology.com/latest-news/omass-raises-310m-in-europes-second-largest-biotech-round-of-2026), [tradingview.com](https://www.tradingview.com/news/reuters.com,2026:newsml_FWN4610EW:0-omass-therapeutics-announces-310-million-series-c-financing) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.